alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol has been researched along with homovanillic acid in 3 studies
| Studies (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Trials (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Recent Studies (post-2010) (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Studies (homovanillic acid) | Trials (homovanillic acid) | Recent Studies (post-2010) (homovanillic acid) |
|---|---|---|---|---|---|
| 90 | 1 | 2 | 6,127 | 312 | 438 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cler, JA; Iyengar, S; Oei, EJ; Rao, TS; Wood, PL | 1 |
| Akunne, H; Caprathe, BW; Jaen, JC; Pugsley, TA; Wise, LD | 1 |
| Korpinen, C; Matos, FF; Yocca, FD | 1 |
3 other study(ies) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and homovanillic acid
| Article | Year |
|---|---|
Increased release of dopamine in vivo by BMY-14802: contrasting pattern to clozapine.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Anti-Anxiety Agents; Brain Chemistry; Clozapine; Corpus Striatum; Dibenzazepines; Dopamine; Homovanillic Acid; Male; Methyltyrosines; Mice; Olfactory Bulb; Pyrimidines | 1990 |
Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and sigma receptors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Brain; Butanols; CHO Cells; Cricetinae; Dopamine; Dopamine Antagonists; Guinea Pigs; Haloperidol; Homovanillic Acid; Humans; Male; Oxidation-Reduction; Piperazines; Pyridines; Pyrimidines; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, sigma; Stereoisomerism | 1993 |
5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus.
Topics: Animals; Anti-Anxiety Agents; Dose-Response Relationship, Drug; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Microdialysis; Piperazines; Pyridines; Pyrimidines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1996 |